FundingWatcher
Home / Funding rounds / Series B funding rounds / Series B startups in Switzerland

Series B startups in Switzerland

Updated 16 Nov 2026

Reset
Series B startups in Switzerland
One-time CSV
  • 124 funded companies, 63 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-round-series-b~switzerland.csv124 rows × 18 columns
CompanyCityLast roundAmountDate
Laza MedicalPfaffikonSeries B$160.0M2026-11-04
NovaGo TherapeuticsSchlierenSeries B$29.7M2026-08-31
Vaderis TherapeuticsBaselSeries B$152.0M2026-08-11
Windward BioBaselSeries B$165.0M2026-05-04
KEMARO AGEschlikonSeries B$5.0M2026-04-23
DelvitechMendrisioSeries B$40.0M2025-11-11
deskbirdPfaffikonSeries B$23.0M2025-09-24
Loft DynamicsZürichSeries B$24.0M2025-08-21

8 rows of the CSV in 5 of its 18 columns.

124
Startups
$3.6B
Total raised
10
Funded in the last 12 months
$601.3M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 124
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Laza Medical Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. Artificial intelligence Pfaffikon Series B $160.0M 2026-11-04 $196.0M Page One Ventures, Unorthodox Ventures, The Capital Partnership 1 to 10 2020
NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
KEMARO AG KEMARO AG engineers autonomous robotics. Artificial intelligence Eschlikon Series B $5.0M 2026-04-23 $10.4M Innosuisse, Spicehaus Partners 11 to 50 2016
Delvitech Delvitech develops sustainable AI-based 3D automated optical inspection solutions for microelectronics. Artificial intelligence Mendrisio Series B $40.0M 2025-11-11 $48.6M TiVentures, Credit Suisse Entrepreneur Capital 51 to 100 2018
Loft Dynamics Loft Dynamics develops virtual reality flight simulators for realistic, affordable, and safe pilot training. Education Zürich Series B $24.0M 2025-08-21 $53.3M Craft Ventures, UP Ventures 51 to 100 2016
Zama Zama provides confidentiality for public blockchains. Cybersecurity Zug Series B $57.0M 2025-06-25 $139.3M Plug and Play, Protocol Labs, Metaplanet +2 51 to 100 2020
GlycoEra GlycoEra researches and produces extracellular protein degraders for treating autoimmune diseases. Biotech Wädenswil Series B $130.0M 2025-05-27 $179.3M Sofinnova Partners, Bristol-Myers Squibb, 5AM Ventures +1 11 to 50 2020
amnis amnis helps businesses cut international transaction costs, manage team spending, and handle daily accounting. Fintech Zürich Series B $11.2M 2025-02-26 $22.8M Spicehaus Partners, Lansdowne Partners 11 to 50 2014
Sparta Sparta helps traders identify market opportunities with clarity and confidence. Energy Geneva Series B $42.0M 2025-02-24 $65.5M FirstMark, Singular 101 to 250 2020
Embotech Embotech provides Level 4 autonomous driving solutions built for industrial logistics applications. Software Zürich Series B $26.3M 2024-12-12 VentureOut, European Innovation Council, FuturePlay 101 to 250 2013
Noema Pharma Noema Pharma develops therapies that treat disabling symptoms of brain and nervous system conditions. Biotech Basel Series B $147.2M 2024-12-11 $316.5M Polaris Partners, Sofinnova Partners, Invus +2 11 to 50 2019
Wyden Wyden is a fintech company that provides digital asset trading services for institutions and asset managers. Fintech Zürich Series B $16.9M 2024-11-12 Verve Ventures, FinLab, Groundshift +1 51 to 100 2014
Retinai RetinAI is a company that simplifies clinic, research, and pharmaceutical workflows to improve healthcare. Artificial intelligence Bern Series B $7.8M 2024-10-16 $16.8M Venture Kick, Verve Ventures, Matterwave Ventures 11 to 50 2016
CorFlow Therapeutics CorFlow Therapeutics develops proprietary technologies to diagnose and treat microvascular obstructions. Biotech Baar Series B $48.5M 2024-09-10 $66.1M Innosuisse, Unorthodox Ventures, Panakes Partners +2 11 to 50 2016
iOnctura iOnctura is a clinical-stage biotechnology company developing treatments for cancer. Biotech Geneva Series B $85.7M 2024-06-20 European Innovation Council, M Ventures, VI Partners +2 11 to 50 2017
Hemotune Hemotune develops a therapeutic blood purification platform for treating health conditions. Biotech Schlieren Series B $15.6M 2024-03-25 Venture Kick, Innosuisse, Gebert Rüf Stiftung 11 to 50 2016
Taurus Taurus provides banking-grade digital asset infrastructure for issuing, custodying, and trading digital assets globally. Fintech Geneva Series B $65.0M 2023-02-13 Deutsche Bank, Credit Suisse, Cedar Mundi Ventures 101 to 250 2018
Ledgy Ledgy is a software company that helps organizations manage equity compensation compliantly and at scale. Fintech Zürich Series B $22.0M 2022-09-21 $33.4M Sequoia Capital, New Enterprise Associates, Speedinvest +2 51 to 100 2017
Sonar Unicorn Sonar provides a verification layer for AI and agentic coding along with automated code review. Artificial intelligence Vernier Series B $412.0M 2022-04-26 $457.0M Insight Partners, General Catalyst, Advent International +1 501 to 1,000 2008
Aeris Health Aeris Health provides smart solutions for monitoring and improving indoor air quality. Health care Zug Series B $8.5M 2021-03-01 $12.8M PreAngel, Sarona Ventures 11 to 50 2014
Crypto Finance Group Crypto Finance provides regulated digital asset and blockchain services to institutional clients. Fintech Zug Series B $14.4M 2020-04-16 Lingfeng Capital, QBN Capital 101 to 250 2017
algrano Algrano is a multi-sided platform that lets coffee producers sell directly to the processing industry. Commerce Zürich Series B $4.0M 2019-12-06 Start-Up Chile, SICTIC, Founderful +2 11 to 50 2015
MaxiVAX MaxiVAX is a Swiss clinical-stage biotechnology company. Biotech Geneva Series B $5.0M 2019-11-27 EIC Accelerator 1 to 10 2005
Amal Therapeutics Amal Therapeutics SA is a privately held Swiss and German biotech startup spun off from the University of Geneva. Biotech Geneva Series B $32.6M 2018-11-12 HTGF (High-Tech Gruenderfonds), Venture Kick, VI Partners +2 11 to 50 2012
Therachon Therachon is a global biotechnology company developing medicines for rare genetic diseases. Biotech Basel Series B $60.0M 2018-08-09 $100.0M Bpifrance, New Enterprise Associates, OrbiMed +2 1 to 10 2014
Muume Muume is an all-in-one device that helps small businesses build and manage their online presence. Fintech Zug Series B $6.2M 2017-08-22 Heliad AG 101 to 250 2013
Coorpacademy Coorpacademy offers learning solutions and MOOCs. Education Lausanne Series B $10.9M 2016-10-26 Serena, Debiopharm Innovation Fund, NextStage 11 to 50 2013
KB Medical KB Medical is a Swiss company that designs, develops, and commercializes the AQrate robotic system. Hardware Lausanne Series B $2.5M 2016-10-25 Venture Kick, Foundation for Innovation and Technology (FIT), Kinled Holding 1 to 10 2012

Table 1. Series B startups in Switzerland: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 124.

Series B startups in Switzerland by month2024-0212024-0312024-0412024-0512024-0612024-0812024-0922024-1022024-1112024-1222025-0222025-0422025-0512025-0622025-0832025-0912025-1112026-0312026-0412026-0522026-0612026-0722026-0822026-111
Figure 1. Series B startups in Switzerland by month of the round. Source: FundingWatcher. Data as of 16 November 2026. Base: 124.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
2 Laza Medical Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. Artificial intelligence Pfaffikon Series B $160.0M 2026-11-04 $196.0M Page One Ventures, Unorthodox Ventures, The Capital Partnership 1 to 10 2020
3 Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
4 NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
5 KEMARO AG KEMARO AG engineers autonomous robotics. Artificial intelligence Eschlikon Series B $5.0M 2026-04-23 $10.4M Innosuisse, Spicehaus Partners 11 to 50 2016

Table 2. Series B startups in Switzerland: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Venture Kick Startup incubator Schlieren, Switzerland 14 11%
2 Verve Ventures Venture capital firm Zug, Switzerland 10 8%
3 VI Partners Venture capital firm Altendorf, Switzerland 6 5%
4 Innosuisse Government investment office Berne, Switzerland 5 4% 1 KEMARO AG
5 Sofinnova Partners Venture capital firm Paris, France 3 2%
6 European Innovation Council Startup accelerator Brussels, Belgium 3 2%
7 Founderful Venture capital firm Zürich, Switzerland 3 2%
8 Foundation for Innovation and Technology (FIT) Entrepreneurship program Lausanne, Switzerland 3 2%
9 Swisscom Ventures Venture capital firm Zürich, Switzerland 3 2%
10 BioMedPartners Venture capital firm Basel, Switzerland 3 2%
11 Novartis Venture Fund Corporate venture arm Basel, Switzerland 3 2%
12 Unorthodox Ventures Family office Austin, United States 2 2% 1 Laza Medical
13 Kinled Holding Private equity firm New York, United States 2 2% 1 NovaGo Therapeutics
14 Novo Holdings Corporate venture arm Hellerup, Denmark 2 2% 1 Windward Bio
15 OrbiMed Private equity firm New York, United States 2 2% 1 Windward Bio

Table 3. Series B startups in Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Software 56 45% $1.4B
Health care 51 41% $2.4B
Biotech 31 25% $1.6B
Hardware 18 15% $156.0M
Fintech 17 14% $86.2M
Artificial intelligence 12 10% $821.2M
Commerce 8 6% $27.3M
Education 4 3% $53.3M
Cybersecurity 3 2% $144.4M
Energy 3 2% $65.5M

Table 4. Series B startups in Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 124 100% $16.9M

Table 5. Series B startups in Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Zürich 34 27%
Geneva 14 11%
Zug 11 9%
Basel 9 7%
Schlieren 6 5%
Lausanne 6 5%
Bern 4 3%
Pfaffikon 3 2%
Vaud 3 2%
Neuchâtel 2 2%
Epalinges 2 2%
Chiasso 1 1%

Table 6. Series B startups in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 10% $160.0M
August 2026 2 20% $181.7M
July 2026 2 20% $38.0M
June 2026 1 10% $18.0M
May 2026 2 20% $198.6M
April 2026 1 10% $5.0M
March 2026 1 10%

Table 7. Series B startups in Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 10 8% $601.3M
2025 12 10% $481.9M
2024 14 11% $541.5M
2023 5 4% $116.9M
2022 10 8% $527.7M
2021 9 7% $171.6M

Table 8. Series B startups in Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 2 2%
2020 to 2022 12 10%
2015 to 2019 41 33%
2010 to 2014 39 31%
Before 2010 30 24%

Table 9. Series B startups in Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 24 20%
11 to 50 53 43%
51 to 100 22 18%
101 to 250 20 16%
501 to 1,000 1 1%
1,001 to 5,000 3 2%

Table 10. Series B startups in Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many series b startups in Switzerland are on the list?
124, in the file dated 16 November 2026. 10 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 124 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Series B startups in Switzerland: 124 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Series B startups in Switzerland by sector

Other funding stages in Switzerland

Series B startups elsewhere

Cite: FundingWatcher, 124 companies in Switzerland whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/rounds/series-b/switzerland/